The primary investment objective of the scheme is to generate long term growth by investing predominantly in a portfolio of equity and equity related instruments. However, there is no assurance or gua
Read MoreThe objective of the scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there
Read MoreThe investment objective of the scheme is to provide investment returns before fees and expenses that closely corresponds to the total returns of the securities as represented by the CRISIL- IBX AAA N
Read MoreThe investment objective of the scheme is to achieve long term capital appreciation by investing in equity and equity related securities of companies that follow conglomerate theme. The scheme does no
Read MoreThe investment objective of the scheme is to seek to generate long term capital appreciation by investing in equity and equity related instruments selected based on quant model theme. However, there i
Read MoreThe investment objective of the scheme is to generate long term capital appreciation by investing in a diversified portfolio of equity and equity related instruments, debt and money market instruments
Read MoreThe investment objective of the scheme is to achieve long-term capital appreciation by investing in Equity & Equity Related Instruments of companies following an Ethical Set of Principles. There is no
Read MoreThe investment objective of the scheme is to provide returns that, before expenses, corresponding to the total returns of the securities as represented by the underlying index, subject to tracking err
Read MoreThe investment objective of the scheme is to provide returns that, before expenses, corresponding to the total returns of the securities as represented by the underlying index, subject to tracking err
Read MoreThe Investment objective of the scheme is to provide long term capital appreciation from an actively managed portfolio of equity and equity related securities of companies engaged in consumption and c
Read More